U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1993
138
Substance Class Protein
Created
by admin
on Mon Mar 31 20:32:33 GMT 2025
Edited
by admin
on Mon Mar 31 20:32:33 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
953A26OA1Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DORNASE ALFA,RDNA
VANDF  
Preferred Name English
DORNASE ALFA
INN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
DORNASE ALFA [PURPLE BOOK CDER]
Common Name English
DORNASE ALPHA
Common Name English
RECOMBINANT DEOXYRIBONUCLEASE (DNASE)
Common Name English
Dornase alfa [WHO-DD]
Common Name English
DORNASE ALFA [MI]
Common Name English
DORNASE ALFA [MART.]
Common Name English
DEOXYRIBONUCLEASE (RECOMBINANT, HUMAN CLONE 18-1 PROTEIN MOIETY)
Common Name English
DORNASE ALFA,RDNA [VANDF]
Common Name English
DORNASE ALFA, RECOMBINANT
Common Name English
DORNASE ALFA [USAN]
Common Name English
PULMOZYME
Brand Name English
DORNASE ALFA, RDNA
Common Name English
DORNASE ALFA [JAN]
Common Name English
dornase alfa [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 48090
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
NCI_THESAURUS C29726
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
NDF-RT N0000007767
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
NDF-RT N0000175958
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
FDA ORPHAN DRUG 851921
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
WHO-VATC QR05CB13
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
FDA ORPHAN DRUG 616617
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
NDF-RT N0000008867
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
NDF-RT N0000007956
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
WHO-ATC R05CB13
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
FDA ORPHAN DRUG 447114
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
FDA ORPHAN DRUG 439614
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
NDF-RT N0000007767
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
Code System Code Type Description
MERCK INDEX
m4177
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY Merck Index
INN
7167
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
DRUG BANK
DB00003
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201431
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
SMS_ID
100000080786
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
CAS
143831-71-4
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
RXCUI
337623
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY RxNorm
DRUG CENTRAL
5135
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
LACTMED
Dornase Alfa
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
WIKIPEDIA
DORNASE ALFA
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
FDA UNII
953A26OA1Y
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
EVMPD
SUB06373MIG
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
USAN
EE-68
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
NCI_THESAURUS
C81664
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
CAS
132053-08-8
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
ALTERNATIVE
DAILYMED
953A26OA1Y
Created by admin on Mon Mar 31 20:32:33 GMT 2025 , Edited by admin on Mon Mar 31 20:32:33 GMT 2025
PRIMARY
From To
1_173 1_209
1_101 1_104
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_18
N 1_106
Related Record Type Details
DORNASE ALFA
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966